Clinical Trial Update: Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of fentanyl ETHYPHARM for breakthrough pain in cancer patients receiving opioid therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Fentanyl ETHYPHARM (fentanyl)

Snippet

Sponsor: Ethypharm | Conditions: Breakthrough Pain, Cancer | Phase 3 | Status: COMPLETED